Ask AI
Practical challenges in MASH Care

CE / CME

Practical Challenges in MASH Care: Expert Guidance in Risk Stratification, Treatment Selection, and Comorbidity Management

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Pharmacists: 0.25 contact hour (0.025 CEUs)

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: July 16, 2025

Expiration: July 15, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 61-year-old patient with T2D (A1C: 7.8%), obesity (BMI: 36 kg/m²), and coronary artery disease is treated with a GLP-1 receptor agonist and statin. After 18 months, the patient has lost 8% of their body weight but liver enzymes remain mildly elevated. Liver biopsy confirms MASH (NAS 5) with F2 fibrosis.

Which of the following is the most appropriate next step in pharmacologic management?